Completed OBSERVATIONAL NCT03387631

Efficacy And Safety Of AL For The Treatment Of Uncomplicated Falciparum Malaria In Mainland Tanzania (TES2016)

Efficacy and Safety of Artemether Lumefantrine for the Treatment of Uncomplicated Malaria in Tanzania

Sponsor: National Institute for Medical Research, Tanzania

Updated 6 times since 2018 Last updated: Dec 22, 2017 Started: Apr 30, 2016 Primary completion: Sep 30, 2016 Completion: Sep 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Uncomplicated Malaria, this trial is completed. The trial is conducted by National Institute for Medical Research, Tanzania and has accumulated 6 data snapshots since 2016. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2018 — Apr 2018 [monthly]

Completed NA

First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute for Medical Research, Tanzania

Data source: National Institute for Medical Research, Tanzania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.